Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDDP + TS-1 chemoradiotherapy followed by surgery for superior sulcus lung tumor
jRCTs031180401Completed
- Start
- Aug 2014
- Modality
- Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin and tegafur + gimeracil + oteracil in non-small cell lung cancer (NSCLC). Primary endpoint: 3-year overall survival. Started Aug 2014; status: completed.
02
Drugs
cisplatintegafur + gimeracil + oteracil
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs031180401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180401.